AMENDED CLOSING AGREEMENTAmended Closing Agreement • August 3rd, 2023 • Bioxytran, Inc • Pharmaceutical preparations
Contract Type FiledAugust 3rd, 2023 Company IndustryThis Amended Closing Agreement (the “Agreement”), dated as of August 1, 2023 (the “Issue Date”), is entered into between Bioxytran, Inc. a Nevada corporation (the “Company”), and TRITON FUNDS LP, a Delaware limited partnership (the “Investor”).